Showing 1 - 5 results of 5 for search 'Spyros Papapetropoulos', query time: 0.03s Refine Results
  1. 1
    A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and Digital Biomarker Selection

    A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential T... by Spyros Papapetropoulos, Margaret S. Lee, Stacey Boyer, Evan J. Newbold

    Published 2019-06-01
    Get full text
    Article
  2. 2
    Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies

    Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies by Spyros Papapetropoulos, Jeffrey M. Gelfand, Takuya Konno, Takeshi Ikeuchi, Angela Pontius, Andreas Meier, Farid Foroutan, Zbigniew K. Wszolek

    Published 2024-03-01
    Get full text
    Article
  3. 3
    Biometric Digital Health Technology for Measuring Motor Function in Parkinson’s Disease: Results from a Feasibility and Patient Satisfaction Study

    Biometric Digital Health Technology for Measuring Motor Function in Parkinson’s Disease: Results from a Feasibility and Patient Satisfaction Study by Georgia Mitsi, Enrique Urrea Mendoza, Benjamin D. Wissel, Elena Barbopoulou, Elena Barbopoulou, Alok K. Dwivedi, Ioannis Tsoulos, Athanassios Stavrakoudis, Alberto J. Espay, Spyros Papapetropoulos

    Published 2017-06-01
    Get full text
    Article
  4. 4
    Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease

    Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease by Shani Cohen, Zeev Waks, Jordan J. Elm, Mark Forrest Gordon, Igor D. Grachev, Leehee Navon-Perry, Shai Fine, Iris Grossman, Spyros Papapetropoulos, Juha-Matti Savola

    Published 2018-12-01
    Get full text
    Article
  5. 5
    Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical Models

    Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical Models by Cristina Meregalli, Yuri Maricich, Guido Cavaletti, Annalisa Canta, Valentina A. Carozzi, Alessia Chiorazzi, Evan Newbold, Paola Marmiroli, Cecilia Ceresa, Arthur Diani, Spyros Papapetropoulos, Margaret S. Lee

    Published 2021-10-01
    Get full text
    Article

Search Tools: